{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:09:40Z","timestamp":1761707380094},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1006\/clim.1999.4820","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:13:49Z","timestamp":1033931629000},"page":"64-72","source":"Crossref","is-referenced-by-count":16,"title":["Immunological Effects of BCG as an Adjuvant in Autologous Tumor Vaccines"],"prefix":"10.1006","volume":"94","author":[{"given":"Qiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Normolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Redman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.1999.4820_RF1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000441-189305000-00001","article-title":"The treatment of malignant tumors by repeated inoculations of erysipe las: With a report of ten original cases","volume":"105","author":"Coley","year":"1978","journal-title":"Am. J. Med. Sci."},{"key":"10.1006\/clim.1999.4820_RF2","first-page":"158","article-title":"Immunological factors which influence response to immunotherapy in malignant melanoma","volume":"68","author":"Morton","year":"1970","journal-title":"Surgery"},{"key":"10.1006\/clim.1999.4820_RF3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001622-199703000-00015","article-title":"Adjuvant therapy for melanoma","volume":"9","author":"Sondak","year":"1997","journal-title":"Curr. Opin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette\u2013Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.1999.4820_RF5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical Bacillus Calmette\u2013Guerin therapy prevents tumor progression and death from superficial bladder cancer: Ten-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J. Urol."},{"key":"10.1006\/clim.1999.4820_RF7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1200\/JCO.1990.8.11.1858","article-title":"Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients","volume":"8","author":"Berd","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","article-title":"Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine","volume":"216","author":"Morton","year":"1992","journal-title":"Ann. Surg."},{"key":"10.1006\/clim.1999.4820_RF9","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.1998.16.9.2913","article-title":"Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine","volume":"16","author":"Hsueh","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1200\/JCO.1994.12.5.1036","article-title":"Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside","volume":"12","author":"Livingston","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.1993.11.3.390","article-title":"Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial","volume":"11","author":"Hoover","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","article-title":"Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial","volume":"353","author":"Vermorken","year":"1999","journal-title":"Lancet"},{"key":"10.1006\/clim.1999.4820_RF13","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.140.7.2453","article-title":"Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization: Culture requirements and characterization of immunologic specificity","volume":"140","author":"Chou","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF14","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.141.5.1775","article-title":"Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors","volume":"141","author":"Chou","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4049\/jimmunol.147.2.729","article-title":"Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2","volume":"147","author":"Yoshizawa","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0008-8749(91)90318-6","article-title":"Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapy","volume":"134","author":"Yoshizawa","year":"1991","journal-title":"Cell. Immunol."},{"key":"10.1006\/clim.1999.4820_RF17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4049\/jimmunol.143.2.740","article-title":"Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity","volume":"143","author":"Shu","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0960-7404(92)90065-S","article-title":"A novel role for autologous tumor cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanoma","volume":"1","author":"Geiger","year":"1992","journal-title":"Surg. Oncol."},{"key":"10.1006\/clim.1999.4820_RF19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002371-199304000-00002","article-title":"Generation of T-cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastases","volume":"13","author":"Geiger","year":"1993","journal-title":"J. Immunother."},{"key":"10.1006\/clim.1999.4820_RF20","first-page":"1043","article-title":"Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro","volume":"53","author":"Chang","year":"1993","journal-title":"Cancer Res."},{"key":"10.1006\/clim.1999.4820_RF21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1997.15.2.796","article-title":"Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2","volume":"15","author":"Chang","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/clim.1999.4820_RF22","first-page":"461","article-title":"Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3\/anti-CD28 activation","volume":"5","author":"Li","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1006\/clim.1999.4820_RF23","series-title":"Encyclopedia of Statistical Sciences","author":"Kotz","year":"1988"},{"key":"10.1006\/clim.1999.4820_RF24","series-title":"Linear and Nonlinear Models for the Analysis of Repeated Measure","author":"Vonesh","year":"1997"},{"key":"10.1006\/clim.1999.4820_RF25","series-title":"SAS\/STAT Software: Changes and Enhancements through Release 6.11","year":"1996"},{"key":"10.1006\/clim.1999.4820_RF26","first-page":"79","article-title":"Research on BCG vaccination","volume":"21","author":"ten Dam","year":"1984","journal-title":"Adv. Tuberculosis Res."},{"key":"10.1006\/clim.1999.4820_RF27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.173.3.647","article-title":"Interferon \u03b3 and tumor necrosis factor have a role in tumor regression mediated by murine CD8+ tumor-infiltrating lymphocytes","volume":"173","author":"Barth","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1999.4820_RF28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0960-7404(94)90003-5","article-title":"Reactivation of murine tumor-infiltrating lymphocytes with solid-phase anti-CD3 antibody: In vitro cytokine production is associated with in vivo efficacy","volume":"3","author":"Goedegebuure","year":"1994","journal-title":"Surg. Oncol."},{"key":"10.1006\/clim.1999.4820_RF29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4049\/jimmunol.160.1.334","article-title":"Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte\/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes","volume":"160","author":"Nagoshi","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01517220","article-title":"Tumor-specific granulocyte\/macrophage colony-stimulating factor and interferon \u03b3 secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells","volume":"41","author":"Aruga","year":"1995","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/clim.1999.4820_RF31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4049\/jimmunol.159.2.664","article-title":"Type 1 versus type 2 cytokine release by V\u03b2 T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role","volume":"159","author":"Aruga","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF32","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.161.6.3033","article-title":"Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile","volume":"161","author":"Hu","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01534428","article-title":"Induction of Th1- and Th2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy","volume":"39","author":"McAveney","year":"1994","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/clim.1999.4820_RF34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<650::AID-IMMU650>3.0.CO;2-M","article-title":"Induction of IFN-\u03b3-producing CD4+ natural killer T cells by Mycobacterium bovis Bacillus Calmette\u2013Guerin","volume":"29","author":"Emoto","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1464-410X.1989.tb05187.x","article-title":"HLA-DR expression by high grade superficial bladder cancer treated with BCG","volume":"63","author":"Prescott","year":"1989","journal-title":"Br. J. Urol."},{"key":"10.1006\/clim.1999.4820_RF36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<128::AID-IJC19>3.0.CO;2-H","article-title":"Bacillus Calmette\u2013Guerin mycobateria stimulate human blood dendritic cells","volume":"70","author":"Thurnher","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1006\/clim.1999.4820_RF37","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF38","first-page":"512","article-title":"Sequential production of Th1 and Th2 cytokines in response to live Bacillus Calmette\u2013Guerin","volume":"86","author":"Sander","year":"1995","journal-title":"Immunology"},{"key":"10.1006\/clim.1999.4820_RF39","first-page":"1510","article-title":"TNF production and T cell recruitment\/activation following intravesical BCG therapy of transitional cell carcinoma of the human bladder","volume":"32","author":"Lattime","year":"1991","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1006\/clim.1999.4820_RF40","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1182\/blood.V91.12.4652","article-title":"The role of tumor necrosis factor a in modulating the quantity peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro","volume":"91","author":"Chen","year":"1998","journal-title":"Blood"},{"key":"10.1006\/clim.1999.4820_RF41","first-page":"1129","article-title":"Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3\/interleukin 2 activated tumor draining lymph node cells","volume":"52","author":"Yoshizawa","year":"1992","journal-title":"Cancer Res."},{"key":"10.1006\/clim.1999.4820_RF42","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.160.7.3444","article-title":"Purification of l-selectinlow cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes","volume":"160","author":"Kagamu","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4820_RF43","first-page":"138","article-title":"Concurrent induction of CD4+ and CD8+ T cells during tumor growth with antitumor reactivity in adoptive immunotherapy","volume":"20","author":"Arca","year":"1997","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661699948209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661699948209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T16:21:42Z","timestamp":1680625302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661699948209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S1521661699948209"],"URL":"https:\/\/doi.org\/10.1006\/clim.1999.4820","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}